Bacillus Calmette-Guérin

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Bacillus Calmette–Guérin is a vaccine against tuberculosis. It is often abbreviated BCG. The vaccine is based on a bovine strain of the bacterium. It was developed by Albert Calmette and Camille Guérin in the 1930s. It looks like the vaccine can also be used to treat certain forms of bladder cancer.[1]

References[change | change source]

  1. De Jager R, Guinan P, Lamm D, u. a.: Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trials. Urology. 1991 Dec;38(6):507-13. PMID 1836081